Amneal Pharmaceuticals (NasdaqGS:AMRX) Q2 2026 Earnings call July 30, 2026 08:30 AM ET Company Participants Tony DiMeo - Head of Investor Relations Chirag Patel - Co-CEO and President Chintu Patel - Co-CEO Tasos Konidaris - EVP and CFO Conference Call Participants Glen Santangelo - Analyst None - Analyst David Amsellem - Analyst Ash Verma - Analyst Matt Dellatorre - Analyst Operator Good morning, and welcome to the Amneal Pharmaceuticals second quarter 2026 earnings call. I will now turn the call over to Am ...